Jynarque (TOLVAPTAN) 15MG X 7/45MG X 7 tab, dosepack,14
Ended Awarded Last action
- Contract number
- 36C26124N0904
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $12,581
Award facts
- Contract value 100% obligated
- $12,580.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
About this award
Otsuka America Pharmaceutical Inc. was awarded a $12.6K firm fixed price delivery order by Veterans Integrated Service Network 21 on September 20, 2024, for Jynarque (tolvaptan) in tablet form—specifically 15mg and 45mg dosages in a 14-day dose pack configuration. The contract, which is not subject to any set-aside designation, is scheduled for ultimate completion on October 20, 2024, with performance taking place in Potomac, Maryland. This delivery order falls under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and supports the Department of Veterans Affairs' mission to provide specialized pharmaceutical treatments to veterans.
This award represents a task order issued under Otsuka America Pharmaceutical Inc.'s larger Blanket Purchase Agreement with the VA's National Acquisition Center, valued at $83.3 million and expiring March 26, 2026. Jynarque, the company's flagship pharmaceutical product, is used to treat autosomal dominant polycystic kidney disease and hyponatremia. As a large pharmaceutical manufacturer headquartered in Rockville, Maryland, Otsuka America Pharmaceutical Inc. maintains an established supplier relationship with the VA across multiple Veterans Integrated Service Networks, delivering critical medications through a streamlined procurement process that enables VA facilities nationwide to access specialized pharmaceutical treatments for veterans.
Quick answers
Who was awarded contract 36C26124N0904?
36C26124N0904 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on September 20, 2024.
How much is contract 36C26124N0904 worth?
The government has obligated $12,581 on 36C26124N0904.
Is contract 36C26124N0904 an order under another contract?
Yes. 36C26124N0904 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26124N0904 competed?
The extent of competition for 36C26124N0904 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award